Every story and comment from the Hacker News API, in a layout borrowed from 2001.
A comment on Drugmakers Are Set to Pay 23andMe Millions to Access Consumer DNA. Parent comment
I do care. But I still think the benefit outweights the downsides.
There are no comments on this comment yet.
I do care. But I still think the benefit outweights the downsides.